Bianca van Veggel

Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer

Bianca van Veggel, Juliana F. Vilacha Madeira R Santos, Sayed M.S. Hashemi et al. · Lung Cancer · 2019 · 92 citations · Full text

Medicine, Osimertinib Treatment, Pathology +6

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC

Bianca van Veggel, Adrianus J. de Langen, Sayed M.S. Hashemi et al. · Journal of Thoracic Oncology · 2018 · 64 citations · Full text

Insertion–positive Advanced Nsclc, Medicine, Immunology +8

High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial

Fenneke Zwierenga, Bianca van Veggel, Lizza Hendriks et al. · Lung Cancer · 2022 · 60 citations · Full text

Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer

Sebastian Michels, Carina Heydt, Bianca van Veggel et al. · JCO Precision Oncology · 2019 · 36 citations · Full text

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy

Bianca van Veggel, Inge M. van Oort, J. Alfred Witjes et al. · Histopathology · 2011 · 21 citations